A compound of structural formula (I) or (II): as HSP90 inhibitors that possess significantly improved bioavailability over comparative compounds, which are suitable for the treatment of hyperproliferative diseases such as cancer, infections, immune disorders, inflammation, and CNS related disorders.
化学结构式(I)或(II)的化合物,作为HSP90
抑制剂具有明显改善的
生物利用度,适用于治疗增殖过度性疾病,如癌症、感染、免疫障碍、炎症和中枢神经系统相关疾病。